CClinicalTrials.gg
CompletedNCT06177782Updated Dec 20, 2023

Accuracy of Tooth Modified Scan Bodies as a Novel Technique

An interventional study of Tooth modified scan bodies and Conventional scan bodies in Digital Technology and Dental, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 25 Years to 45 Years. Per ClinicalTrials.gov, last updated 2023-12-20.

Sponsored by Ain Shams University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Jan 2023, registered Dec 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
25 Years to 45 Years
Sex
All
01

Study summary

The clinical performance of a novel scan body Tooth Modified Scan Body (TMSB) in the degree of trueness of IOS impression for full arch cases.

I

Read the detailed description

The clinical performance of a novel scan body Tooth Modified Scan Body (TMSB) in the degree of trueness of IOS impression for full arch cases. TMSB is a scan body to which different teeth are attached directly as one piece, this may enhance the accuracy level by filling the gabs between ISB as well as acting as a stable artificial AI-easily recognized landmarks thus facilitating the scanning procedure. OS impression utilizing tooth modified scan bodies or conventional scan bodies result in the same degree of trueness as conventional verified splinted open tray impression. To our knowledge, it is the first time in the literature to utilize a novel scan body modified with directly connected teeth as artificial landmarks in vivo.

02

Conditions studied

  • Digital Technology
  • Dental

Keywords

  • Jaw relation
  • Scan body
03

In context

Lead sponsor

Ain Shams University is the lead sponsor of 1,879 studies on the registry; 424 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participants who had received 4-6 implants in 1 edentulous arch.
  • Participants with 1-piece implant-supported complete-arch fixed dental prostheses.
  • Systemically free.
  • Primary implant stability exceed 72 the day of the definitive impression.

Exclusion criteria

Exclusion Criteria:

  • Smoker's.
  • Non co-operative patients.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Tooth Modified Scan Bodies

    The intraoral scanner (IOS) impression will be recorded using modified scan bodies. The IOS device will be calibrated right before the impression. The scan strategy will be consistent for all the procedures following the manufacturer guidelines.

    Device: Tooth modified scan bodies

  • Placebo comparator
    Conventional Scan Bodies

    The intraoral scanner (IOS) impression will be recorded using conventional implant scan bodies secured at the multiunit abutment level.

    Device: Conventional scan bodies

Interventions

  • DeviceTooth modified scan bodies

    Tooth modified scan bodies are used during scanning for full arch implant cases.

  • DeviceConventional scan bodies

    Conventional scan bodies will be used for scanning the full arch implant cases.

06

What researchers measure

Primary outcomes

  1. Degree of trueness

    Digital files will be obtained: either conventional scan or TMSB scan. All the STL files will be imported to dental CAD software , and scan bodies will be converted to implant multi-unit ti-base replicas using a digital library. Then, updated STL files will be imported to inspection software for trueness assessments.

    Time frame: Immediately postoperative

07

Study locations

1 site
  • Ain Shams University
    Cairo, Abbassia 11566, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 20, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06177782
Lead sponsor
Ain Shams University
Collaborators
Assiut University
Responsible party
Doaa Adel Salah Khattab (Associate Professor, Ain Shams University) — Principal investigator
First posted
Dec 20, 2023
Start date
Jan 10, 2023
Primary completion
Oct 18, 2023
Completion
Nov 20, 2023
Last update
Dec 20, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion